Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.

Laplaud DA, Casey R, Barbin L, Debouverie M, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Lubetzki C, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Wahab A, Labauge P, Magy L, Defer G, Guennoc AM, Maubeuge N, Labeyrie C, Patry I, Nifle C, Casez O, Michel L, Rollot F, Leray E, Vukusic S, Foucher Y; SFSEP and OFSEP groups.

Neurology. 2019 Aug 13;93(7):e635-e646. doi: 10.1212/WNL.0000000000007938. Epub 2019 Jul 12.

PMID:
31300547
2.

Decreasing impact of late relapses on disability worsening in secondary progressive multiple sclerosis.

Ahrweiller K, Rousseau C, Le Page E, Bajeux E, Leray E, Michel L, Edan G, Kerbrat A.

Mult Scler. 2019 May 16:1352458519848090. doi: 10.1177/1352458519848090. [Epub ahead of print]

PMID:
31094285
3.

Multiple sclerosis: effect of beta interferon treatment on survival.

Kingwell E, Leray E, Zhu F, Petkau J, Edan G, Oger J, Tremlett H.

Brain. 2019 May 1;142(5):1324-1333. doi: 10.1093/brain/awz055.

PMID:
30883636
4.
5.

Factors Associated with Parent-Child Discrepancies in Reports of Mental Health Disorders in Young Children.

Bajeux E, Klemanski DH, Husky M, Leray E, Chan Chee C, Shojaei T, Fermanian C, Kovess-Masfety V.

Child Psychiatry Hum Dev. 2018 Dec;49(6):1003-1010. doi: 10.1007/s10578-018-0815-7.

PMID:
29869765
6.

Use of state sequence analysis for care pathway analysis: The example of multiple sclerosis.

Roux J, Grimaud O, Leray E.

Stat Methods Med Res. 2019 Jun;28(6):1651-1663. doi: 10.1177/0962280218772068. Epub 2018 May 2.

7.

Ozone, NO2 and PM10 are associated with the occurrence of multiple sclerosis relapses. Evidence from seasonal multi-pollutant analyses.

Jeanjean M, Bind MA, Roux J, Ongagna JC, de Sèze J, Bard D, Leray E.

Environ Res. 2018 May;163:43-52. doi: 10.1016/j.envres.2018.01.040. Epub 2018 Feb 6.

8.

Air pollution by particulate matter PM10 may trigger multiple sclerosis relapses.

Roux J, Bard D, Le Pabic E, Segala C, Reis J, Ongagna JC, de Sèze J, Leray E.

Environ Res. 2017 Jul;156:404-410. doi: 10.1016/j.envres.2017.03.049. Epub 2017 Apr 11.

PMID:
28407574
9.

[Identification of neurodegenerative diseases in administrative databases in France: A systematic review of the literature].

Gallini A, Moisan F, Maura G, Carcaillon-Bentata L, Leray E, Haesebaert J, Bruandet A, Moutengou E, Luciano L, Weill A, Marin B, Gardette V.

Rev Epidemiol Sante Publique. 2017 Oct;65 Suppl 4:S183-S197. doi: 10.1016/j.respe.2017.01.115. Epub 2017 Mar 22. Review. French.

PMID:
28341166
10.

An excessive risk of suicide may no longer be a reality for multiple sclerosis patients.

Kalson-Ray S, Edan G, Leray E; SURVIMUS Study Group.

Mult Scler. 2017 May;23(6):864-871. doi: 10.1177/1352458517699873. Epub 2017 Mar 16.

PMID:
28299961
11.

Geographical Heterogeneity of Multiple Sclerosis Prevalence in France.

Pivot D, Debouverie M, Grzebyk M, Brassat D, Clanet M, Clavelou P, Confavreux C, Edan G, Leray E, Moreau T, Vukusic S, Hédelin G, Guillemin F.

PLoS One. 2016 Dec 9;11(12):e0167556. doi: 10.1371/journal.pone.0167556. eCollection 2016.

12.

Corrigendum to "Bereavement-related depression: Did the changes induced by DSM-V make a difference? Results from a large population-based survey of French residents"[J. Affect. Disord. 182 (2015) 82-90].

Clesse F, Leray E, Bodeau-Livinec F, Husky M, Kovess-Masfety V.

J Affect Disord. 2017 Jan 1;207:53. doi: 10.1016/j.jad.2016.09.009. Epub 2016 Sep 29. No abstract available.

PMID:
27693465
13.

Mental health of college students and their non-college-attending peers: results from a large French cross-sectional survey.

Kovess-Masfety V, Leray E, Denis L, Husky M, Pitrou I, Bodeau-Livinec F.

BMC Psychol. 2016 Apr 21;4:20. doi: 10.1186/s40359-016-0124-5.

14.

Epidemiology of multiple sclerosis.

Leray E, Moreau T, Fromont A, Edan G.

Rev Neurol (Paris). 2016 Jan;172(1):3-13. doi: 10.1016/j.neurol.2015.10.006. Epub 2015 Dec 21.

PMID:
26718593
15.

Air pollution, a rising environmental risk factor for cognition, neuroinflammation and neurodegeneration: The clinical impact on children and beyond.

Calderón-Garcidueñas L, Leray E, Heydarpour P, Torres-Jardón R, Reis J.

Rev Neurol (Paris). 2016 Jan;172(1):69-80. doi: 10.1016/j.neurol.2015.10.008. Epub 2015 Dec 21. Review.

16.

[Epidemiology of multiple sclerosis and new diagnostic criteria]

Leray E, Vukusic S.

Rev Prat. 2016 Jan;66(1):32-36. French.

PMID:
30512395
17.

Preservation of Person-Specific Semantic Knowledge in Semantic Dementia: Does Direct Personal Experience Have a Specific Role?

Péron JA, Piolino P, Moal-Boursiquot SL, Biseul I, Leray E, Bon L, Desgranges B, Eustache F, Belliard S.

Front Hum Neurosci. 2015 Nov 19;9:625. doi: 10.3389/fnhum.2015.00625. eCollection 2015.

18.

Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.

Leray E, Vukusic S, Debouverie M, Clanet M, Brochet B, de Sèze J, Zéphir H, Defer G, Lebrun-Frenay C, Moreau T, Clavelou P, Pelletier J, Berger E, Cabre P, Camdessanché JP, Kalson-Ray S, Confavreux C, Edan G.

PLoS One. 2015 Jul 6;10(7):e0132033. doi: 10.1371/journal.pone.0132033. eCollection 2015.

19.

Bereavement-related depression: Did the changes induced by DSM-V make a difference? Results from a large population-based survey of French residents.

Clesse F, Leray E, Bodeau-Livinec F, Husky M, Kovess-Masfety V.

J Affect Disord. 2015 Aug 15;182:82-90. doi: 10.1016/j.jad.2015.04.039. Epub 2015 Apr 30. Erratum in: J Affect Disord. 2016 Jan 15;190:369. J Affect Disord. 2017 Jan 1;207 :53.

PMID:
25978718
20.

Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study.

Le Page E, Deburghgraeve V, Lester MA, Cardiet I, Leray E, Edan G.

J Neurol. 2015;262(4):1024-34. doi: 10.1007/s00415-015-7653-3. Epub 2015 Feb 21.

PMID:
25701008
21.

Criteria improving multiple sclerosis diagnosis at the first MRI.

Caucheteux N, Maarouf A, Genevray M, Leray E, Deschamps R, Chaunu MP, Daelman L, Ferré JC, Gout O, Pelletier J, Pierot L, Edan G, Tourbah A.

J Neurol. 2015;262(4):979-87. doi: 10.1007/s00415-015-7668-9. Epub 2015 Feb 17.

PMID:
25683762
22.

Parental use of corporal punishment in Europe: intersection between public health and policy.

duRivage N, Keyes K, Leray E, Pez O, Bitfoi A, Koç C, Goelitz D, Kuijpers R, Lesinskiene S, Mihova Z, Otten R, Fermanian C, Kovess-Masfety V.

PLoS One. 2015 Feb 12;10(2):e0118059. doi: 10.1371/journal.pone.0118059. eCollection 2015.

23.

Psychotropic medication use in French children and adolescents.

Kovess V, Choppin S, Gao F, Pivette M, Husky M, Leray E.

J Child Adolesc Psychopharmacol. 2015 Mar;25(2):168-75. doi: 10.1089/cap.2014.0058. Epub 2015 Jan 13.

PMID:
25584837
24.

Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.

Kerbrat A, Hamonic S, Leray E, Tron I, Edan G, Yaouanq J; West Neuroscience Network of Excellence (WENNE).

Eur J Neurol. 2015 Mar;22(3):507-e35. doi: 10.1111/ene.12600. Epub 2014 Dec 16.

PMID:
25515927
25.

Register-based incidence of multiple sclerosis in Brittany (north-western France), 2000-2001.

Yaouanq J, Tron I, Kerbrat A, Leray E, Hamonic S, Merienne M, Hinault P, Edan G.

Acta Neurol Scand. 2015 May;131(5):321-8. doi: 10.1111/ane.12332. Epub 2014 Oct 14.

26.

Mortality following stroke during and after acute care according to neighbourhood deprivation: a disease registry study.

Grimaud O, Leray E, Lalloué B, Aghzaf R, Durier J, Giroud M, Béjot Y.

J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1313-8. doi: 10.1136/jnnp-2013-307283. Epub 2014 Mar 19.

PMID:
24648038
27.

Improving detection of ischemic lesions at 3 Tesla with optimized diffusion-weighted magnetic resonance imaging.

Ract I, Ferré JC, Ronzière T, Leray E, Carsin-Nicol B, Gauvrit JY.

J Neuroradiol. 2014 Mar;41(1):45-51. doi: 10.1016/j.neurad.2013.04.003. Epub 2013 Jun 12.

PMID:
23764260
28.

Relevancy and reproducibility of magnetic resonance imaging (MRI) interpretation in multiple-ligament injuries and dislocations of the knee.

Barbier O, Galaud B, Descamps S, Boisrenoult P, Leray E, Lustig S, Bonnevialle P, Laffargue P, Paillot JL, Rosset P, Neyret P, Saragaglia D, Lapra C; French Society of Orthopaedic Surgery and Traumatology (SoFCOT).

Orthop Traumatol Surg Res. 2013 May;99(3):305-11. doi: 10.1016/j.otsr.2012.11.016. Epub 2013 Mar 9.

29.

Knowledge of TIA among general practitioners and emergency department physicians. A questionnaire survey in a French semi-rural area.

Massengo SA, Cisse M, Guiziou C, Leray E, Rajabally YA, Edan G.

Clin Neurol Neurosurg. 2013 Aug;115(8):1457-63. doi: 10.1016/j.clineuro.2013.01.026. Epub 2013 Feb 27.

PMID:
23454886
30.

'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.

Leray E, Coustans M, Le Page E, Yaouanq J, Oger J, Edan G.

Mult Scler. 2013 Apr;19(4):458-65. doi: 10.1177/1352458512456613. Epub 2012 Aug 2.

PMID:
22859724
31.

Apomorphine infusion in advanced Parkinson's patients with subthalamic stimulation contraindications.

Drapier S, Gillioz AS, Leray E, Péron J, Rouaud T, Marchand A, Vérin M.

Parkinsonism Relat Disord. 2012 Jan;18(1):40-4. doi: 10.1016/j.parkreldis.2011.08.010. Epub 2011 Sep 3.

PMID:
21890396
32.

Natalizumab and drug holiday in clinical practice: an observational study in very active relapsing remitting multiple sclerosis patients.

Kerbrat A, Le Page E, Leray E, Anani T, Coustans M, Desormeaux C, Guiziou C, Kassiotis P, Lallement F, Laplaud D, Diraison P, Rouhart F, Sartori E, Wardi R, Wiertlewski S, Edan G.

J Neurol Sci. 2011 Sep 15;308(1-2):98-102. doi: 10.1016/j.jns.2011.05.043. Epub 2011 Jun 12.

PMID:
21665227
33.

Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial.

Edan G, Comi G, Le Page E, Leray E, Rocca MA, Filippi M; French–Italian Mitoxantrone Interferon-beta-1b Trial Group.

J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1344-50. doi: 10.1136/jnnp.2010.229724. Epub 2011 Mar 24.

PMID:
21436229
34.

Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study.

Le Page E, Leray E, Edan G; French Mitoxantrone Safety Group.

Mult Scler. 2011 Jul;17(7):867-75. doi: 10.1177/1352458511398371. Epub 2011 Feb 15.

PMID:
21325016
35.

Major depressive disorder skews the recognition of emotional prosody.

Péron J, El Tamer S, Grandjean D, Leray E, Travers D, Drapier D, Vérin M, Millet B.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):987-96. doi: 10.1016/j.pnpbp.2011.01.019. Epub 2011 Feb 4.

PMID:
21296120
36.

A new treatment era in multiple sclerosis: clinical applications of new concepts.

Edan G, Leray E.

J Neurol Sci. 2011 Jul 15;306(1-2):170-2. doi: 10.1016/j.jns.2010.09.018. Epub 2010 Oct 16.

PMID:
20951999
37.

Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography study.

Le Jeune F, Vérin M, N'Diaye K, Drapier D, Leray E, Du Montcel ST, Baup N, Pelissolo A, Polosan M, Mallet L, Yelnik J, Devaux B, Fontaine D, Chereau I, Bourguignon A, Peron J, Sauleau P, Raoul S, Garin E, Krebs MO, Jaafari N, Millet B; French Stimulation dans le trouble obsessionnel compulsif (STOC) study group.

Biol Psychiatry. 2010 Dec 1;68(11):1016-22. doi: 10.1016/j.biopsych.2010.06.033. Epub 2010 Oct 16.

PMID:
20951978
38.

Longitudinal study of bone mineral density in children after a diagnosis of Crohn's disease.

Samson F, Cagnard B, Leray E, Guggenbuhl P, Bridoux-Henno L, Dabadie A.

Gastroenterol Clin Biol. 2010 Oct;34(10):554-61. doi: 10.1016/j.gcb.2010.01.024. Epub 2010 Aug 23.

39.

[Can we explain the sudden infant death syndrome? About a series of 80 cases with an autopsy in Rennes University Hospital, France in the period 1994-2007].

Saint-Stéban C, Leray E, Jouan H, Loget P, Venisse A, Roussey M.

Arch Pediatr. 2010 Aug;17(8):1231-6. doi: 10.1016/j.arcped.2010.05.016. Epub 2010 Jul 7. French.

PMID:
20615676
40.

Influence of job seniority, hand hygiene education, and patient-to-nurse ratio on hand disinfection compliance.

Buffet-Bataillon S, Leray E, Poisson M, Michelet C, Bonnaure-Mallet M, Cormier M.

J Hosp Infect. 2010 Sep;76(1):32-5. doi: 10.1016/j.jhin.2010.02.024. Epub 2010 May 6.

PMID:
20451299
41.

Prevalence, characteristics and comorbidities of anxiety disorders in France: results from the "Mental Health in General Population" survey (MHGP).

Leray E, Camara A, Drapier D, Riou F, Bougeant N, Pelissolo A, Lloyd KR, Bellamy V, Roelandt JL, Millet B.

Eur Psychiatry. 2011 Sep;26(6):339-45. doi: 10.1016/j.eurpsy.2009.12.001. Epub 2010 Apr 28.

PMID:
20430592
42.

Evidence for a two-stage disability progression in multiple sclerosis.

Leray E, Yaouanq J, Le Page E, Coustans M, Laplaud D, Oger J, Edan G.

Brain. 2010 Jul;133(Pt 7):1900-13. doi: 10.1093/brain/awq076. Epub 2010 Apr 27.

43.

Psychological effects of false-positive results in cystic fibrosis newborn screening: a two-year follow-up.

Beucher J, Leray E, Deneuville E, Roblin M, Pin I, Bremont F, Turck D, Giniès JL, Foucaud P, Rault G, Derelle J, David V, Journel H, Marchand S, Veillard D, Roussey M.

J Pediatr. 2010 May;156(5):771-6, 776.e1. doi: 10.1016/j.jpeds.2009.12.003. Epub 2010 Feb 20.

PMID:
20171652
44.

Diagnostic accuracy of esophageal capsule endoscopy versus conventional upper digestive endoscopy for suspected esophageal squamous cell carcinoma.

Heresbach D, Leray E, d'Halluin PN, Cholet F, Lapalus MG, Gaudric M, Ben Soussan E, Gaudin JL, Vahedi K, Quentin V, Filoche B, Saurin JC, Chaussade S, Ponchon T.

Endoscopy. 2010 Feb;42(2):93-7. doi: 10.1055/s-0029-1243856. Epub 2010 Feb 5.

PMID:
20140825
45.

Subthalamic nucleus stimulation affects fear and sadness recognition in Parkinson's disease.

Péron J, Biseul I, Leray E, Vicente S, Le Jeune F, Drapier S, Drapier D, Sauleau P, Haegelen C, Vérin M.

Neuropsychology. 2010 Jan;24(1):1-8. doi: 10.1037/a0017433.

PMID:
20063943
46.

3,4-diaminopyridine safety in clinical practice: an observational, retrospective cohort study.

Flet L, Polard E, Guillard O, Leray E, Allain H, Javaudin L, Edan G.

J Neurol. 2010 Jun;257(6):937-46. doi: 10.1007/s00415-009-5442-6. Epub 2010 Jan 8.

PMID:
20058019
47.

Long-term retention deficit involvement in prodromal Alzheimer's disease.

Jonin PY, Vichard H, Leray E, Sarazin M, Dubois B, Belliard S; PréAl study group.

Behav Neurol. 2010;23(4):169-71. doi: 10.3233/BEN-2010-0286. No abstract available.

48.

Dislocation and bicruciate lesions of the knee: epidemiology and acute stage assessment in a prospective series.

Lustig S, Leray E, Boisrenoult P, Trojani C, Laffargue P, Saragaglia D, Rosset P, Neyret P; French Society of Orthopedic Surgery and Traumatology.

Orthop Traumatol Surg Res. 2009 Dec;95(8):614-20. doi: 10.1016/j.otsr.2009.10.005.

49.

Vascular lesions associated with bicruciate and knee dislocation ligamentous injury.

Boisrenoult P, Lustig S, Bonneviale P, Leray E, Versier G, Neyret P, Rosset P, Saragaglia D; French Society of Orthopedic Surgery and Traumatology (SOFCOT).

Orthop Traumatol Surg Res. 2009 Dec;95(8):621-6. doi: 10.1016/j.otsr.2009.10.002.

50.

Variations between endoscopists in rates of detection of colorectal neoplasia and their impact on a regional screening program based on colonoscopy after fecal occult blood testing.

Bretagne JF, Hamonic S, Piette C, Manfredi S, Leray E, Durand G, Riou F.

Gastrointest Endosc. 2010 Feb;71(2):335-41. doi: 10.1016/j.gie.2009.08.032. Epub 2009 Nov 17.

PMID:
19922930

Supplemental Content

Support Center